• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Progressively increasing CA19-9 sounded the alarm of an intra-hepatic cholangiocarcinoma

Progressively increasing CA19-9 sounded the alarm of an intra-hepatic cholangiocarcinoma

Dandan Hu1, Yilei Mao2. 1Sun Yat-sen University Cancer Center, 2Peking Union Medical College Hospital

Potential good prognosis of preclinical cholangiocarcinoma underwent laparoscopic liver segmentectomy.

A 76 years old male presented to gastroenterology department on January 4, 2016, with progressively increasing carbohydrate antigen 19-9 (Ca19-9) level.

Clinical manifestations only include a blood stool with less than 10ml/d, with occasionally tenesmus. No special findings about physical examinations.

Past history includes middle segmentectomy of left lung in 1964, post-operation pathology implied tuberculosis. In 2013, he went through radical prostatectomy (Gleason 3+3, T2cN0Mo). In 2014, he was discovered to have elevated PSA level and went through 1-month radiotherapy. Now, he is on oral bicalutamide medication. In 2015, as he developed groin hernia, a tension-free hernioplasty was performed. He has hypertension, diabetes mellitus, and hemorrhoid as well. He also has 5-years history of hypertension, diabetes mellitus, and hemorrhoids.

Ca19-9 level was 237.9 (reference range: 0-34.0) on October 28, 2015. It rose to 310.5 on December 2, 2015. After admission, another test was done on January 4, 2016, and the figure rocketed to 338.3. Meanwhile, Ca242 were 118.9, >150, > 150 respectively (0-20), cyfra 211 were 8.11, 9.22, 6.36 respectively (0-3.5). AFP and CEA were negative.

As for this patient, he is of high risk of hepatobiliary system diseases. Due to common bile duct calculi, ERCP was applied in 2010. He was affected by recurrent cystitis, and an open cystectomy surgery was performed in 2011, along with common bile duct incision, lithotomy under choledochoscope, and T tube drainage. Post-surgical pathology showed no evidence of tumor cells. His serum tests indicated that he was previously infected with hepatitis virus B.

After admission, a contrast enhanced computer tomography was performed and no malignancy was reported. PET/CT was suggested and a 3.6*3.7*2.7cm high standard uptake value (SUVmax=6.0) lesion was indicated at the margin of left lobe of liver, where it can hardly distinguish the relationship between the lesion and lesser curvature of stomach.

After consultation by Department of Liver Surgery, laparoscopic left liver segmentectomy under general anesthesia was performed on January 19, 2016. The surgery lasted for 200 minutes, with less than 100ml bleeding. The lesion was 3*1.8*2.5cm, soft, parenchymal, partly enveloped, and its section is gray and poorly demarcated. Pathology reported it was poorly differentiated cholangiocarcinoma with necrosis, AFP(-), CAM5.2(+), CD34(vessel +), CEA(+), CK19(+), CK7(+), CK8(+), EGFR(+), Hepatocyte(-), Ki-67(index 30%). Margin was negative.

Ca19-9 dropped to 107 7 days after the surgery.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 86228

Program Number: P129

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

294

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals